Experts question continuation of Covishield vaccine trials in India despite adverse event report
Censure SII’s move to file a defamation suit on the participant who reported the adverse event, stating that it will discourage…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Amar Jesani
Patient activist groups express relief over pause of Covishield trials in India
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety